Renewed: Protocol for a randomised controlled trial of a digital intervention to support quality of life in cancer survivors.
Clicks: 439
ID: 59492
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
71.3
/100
439 views
303 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #23 of 442 articles by views in BMJ open
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 442 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Low quality of life is common in cancer survivors. Increasing physical activity, improving diet, supporting psychological well-being and weight loss can improve quality of life in several cancers and may limit relapse. The aim of the randomised controlled trial outlined in this protocol is to examine whether a digital intervention (Renewed), with or without human support, can improve quality of life in cancer survivors. Renewed provides support for increasing physical activity, managing difficult emotions, eating a healthier diet and weight management.A randomised controlled trial is being conducted comparing usual care, access to Renewed or access to Renewed with brief human support. Cancer survivors who have had colorectal, breast or prostate cancer will be identified and invited through general practice searches and mail-outs. Participants are asked to complete baseline measures immediately after screening and will then be randomised to a study group; this is all completed on the Renewed website. The primary outcome is quality of life measured by the European Organization for Research and Treatment of Cancer QLQ-c30. Secondary outcomes include anxiety and depression, fear of cancer recurrence, general well-being, enablement and items relating to costs for a health economics analysis. Process measures include perceptions of human support, intervention usage and satisfaction, and adherence to behavioural changes. Qualitative process evaluations will be conducted with patients and healthcare staff providing support.The trial has been approved by the NHS Research Ethics Committee (Reference 18/NW/0013). The results of this trial will be published in peer-reviewed journals and through conference presentations.ISRCTN96374224; Pre-results.
| Reference Key |
krusche2019renewedbmj
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Krusche, Adele;Bradbury, Katherine;Corbett, Teresa;Barnett, Jane;Stuart, Beth;Yao, Guiqing Lily;Bacon, Roger;Böhning, Dankmar;Cheetham-Blake, Tara;Eccles, Diana;Foster, Claire;Geraghty, Adam William Alfred;Leydon, Geraldine;Müller, Andre;Neal, Richard D;Osborne, Richard;Rathod, Shanaya;Richardson, Alison;Sharman, Geoffrey;Summers, Kevin;Watson, Eila;Wilde, Laura;Wilkinson, Clare;Yardley, Lucy;Little, Paul; |
| Journal | BMJ open |
| Year | 2019 |
| DOI |
10.1136/bmjopen-2018-024862
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.